print header
Print Page

Speaker Presentations Tuesday 18 October

Speaker presentations have been attached where consent has been given by speakers to allow delegates access to their presentation slides, otherwise links to the contacts page for direct communication with the speaker has been provided as an alternative. 

PLENARY 9.00AM - 11.00AM

PLENARY 3 –  Patients First - New Models in Pharmaceutical R&D 
Dr Paul Stoffels, Worldwide Chairman, Janssen, Pharmaceutical Companies of Johnson & Johnson

PLENARY 4 – Translating health discovery into clinical applications: an Australian perspective
Prof Ross McKinnon, Research Director and Professor in Cancer Research, Flinders Centre for Innovation in Cancer, School of Medicine, Flinders University

 

CONFERENCE SESSIONS 11.30AM – 1.00PM

Medtech - Health Techology Assessment Implementation
Warren Bingham, President, Australia & New Zealand, Given Imaging Pty Ltd
Dr Sarah Norris, Co-Director, Health Technology Analysts
Prof Brendon Kearney, Site Clinical Director RAH, Haemotology, SA Pathology

Human Health - Coding, Payment and Coverage: Emerging Issues for Drug & Device Companies Accessing North American and European Territories
Paul MacLeman, CEO, Genetic Technologies
Michael Wonder, Wonder Drug Consulting

General - Sourcing capital?  Improve your investment readiness and valuation through better IP management
Ian Lewis, Director SAMIAN Underwriting, United Kingdom
Dr Rob Crombie, Managing Director, Concept2Clinic Consulting
Rob McInnes, Partner, Intellectual Property & Technology, Dibbs Barker
Michael Quinn, Managing Partner, Innovation Capital

Investment Business - Transpacific Biotech Capital: Case Studies Sourcing Human & Financial Capital for Biotech
Dr Anthony Sun, Partner, Aisling Capital, United States
Dr Richard Treagus, CEO, Acrux
Dr Greg Collier, Managing Director, Barwon Biotechnology

CONFERENCE SESSIONS 2.00PM – 3.30PM

Human Health - Development of Biopharmaceuticals in Australia: Pathways to Success in a Global Setting
Anne-Maree Keane, Partner, Transaction Advisory Services, Ernst & Young
Terry Hurst, CEO, Q-Pharm Pty Ltd
Dr Dianne Jackson-Matthews, Director of Regulatory Affairs, ERA Consulting
Robert Gay, Director Manufacturing, Cephalon Australia Pty Ltd
Marc Goemans, Senior Director New Business Development Asia-Pacific, DSM Biologics, Netherlands

General - IP Reform in Australia: A Health & Status Check
Naomi Pearce, IP Director & Counsel, Hospira Australia Pty Ltd
Kim O'Connell, Partner, Mallesons Stephen Jaques
Dr Jenny Petering, Partner, FB Rice
Dr Kristy McCamley, Intellectual Property Manager & Patent Attorney, Research, Biota Holdings Limited

Investment Business - International Investors Unplugged
Clarke Futch, Managing Partner, Cowen Healthcare Royalty Partners, United States
Lawrence Gozlan, CEO, Scientia Capital, Australia
Dr Ron Laufer, Managing Director, Medimmune Ventures, United States
Dr William Shen, Partner, Venbio, United States
Joe Sum, Vice President, Biotechnology Value Fund, United States
Dr Anthony Sun, Partner, Aisling Capital, United States

CONFERENCE SESSIONS 4.00PM – 5.30PM

AG Industrial Environmental - Biotechnology in winemaking: adding value to a 7000 year old product
Dr Ian Dry, Principal Scientist, CSIRO's Plant Industry Division
Prof Sakkie Pretorius, Managing Director, The Australian Wine Research Institute
Patricia Osidacz, Senior Sensory Scientist, The Australian Wine Research Institute 

Human Health - Clever cell culture for the innovation of biologics
Dr Jonathan Arthur, General Manager, CellBank Australia
Dr George Lovrecz, Head of Fermentation Group, Material Science & Engingeering, CSIRO
Prof Roger Reddel, Director, Children's Medical Research Institute
Dr Verma McErlane, Director of Commercial Operations International, Sistemic, Scotland

General - Biomanufacturing
Dr Anne Collins, Associate Director, One 2 One BioSciences, Hospira Adelaide
Hans-Peter Grau, Vice President Business Development, Boehringer Ingelheim Pharma GmbH & Co, KG Germany
Dr Klaus B Schoepe, Senior Vice President Client Relations, Rentschler Biotechnologie, Germany
Dr Simon Green, Senior Vice President Global R&D Product Development, CSL Limited

Investment Business - Partnering and other non equity diluting strategies
Samantha Cobb, CEO, AdAlta Pty Ltd
Dr Esra Ogru, CEO, Phosphagenics
Dr Alexandra Tickle, Commercialisation Manager, Otago Innovation, New Zealand
Dr Stella Xu, Regional Head, Greater China & Souteast Asia, Roche Partnering, Shanghai China
Nick Woolf, CFO VP Corporate Development, Phylogica Ltd

AusBiotech thanks the following event partners:


BioInnovations celbrating 20 years

 

The Business Matching Program is powered by